INTERNATIONAL PATENT: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD., 博瑞生物医药（苏州）股份有限公司 FILES APPLICATION FOR "COMBINATION OF GLP-1R/GIPR DUAL AGONIST AND FGF21 COMPOUND AND USE"

GENEVA, Oct. 26 -- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (Building C25, No. 218 Xinghu Street, Bio-BAY, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 博瑞生物医药（苏州）股份有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物纳米园C25栋) filed a patent application (PCT/CN2025/089290) for "COMBINATION OF GLP-1R/GIPR DUAL AGONIST AND FGF21 COMPOUND AND USE" on Apr 16, 2025. With publication no. WO/2025/218701, the details related to the patent application was published on Oct 23, 2025.

Notably, th...